CMG Pharmaceutical Co. Ltd (058820) — Strategic Asset Allocation Index
CMG Pharmaceutical Co. Ltd (058820) has a Strategic Asset Allocation Index of 42.6% as of March 2025. Strategic assets (PP&E of ₩79.99 Billion plus long-term investments of ₩-) total ₩79.99 Billion, measured against net assets of ₩187.98 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
CMG Pharmaceutical Co. Ltd Strategic Asset Allocation Index (2011–2024)
This chart shows how CMG Pharmaceutical Co. Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2011 to 2024. As of March 2025, the index stands at 42.6%, representing strategic assets of ₩79.99 Billion against net assets of ₩187.98 Billion KRW. Explore 058820 operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for CMG Pharmaceutical Co. Ltd (2011–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for CMG Pharmaceutical Co. Ltd from 2011 to 2024, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see CMG Pharmaceutical Co. Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 41.1% | ₩77.98 Billion | ₩77.98 Billion | ₩- | ₩189.54 Billion | ▲ +14.5 pp |
| 2023 | 26.7% | ₩50.71 Billion | ₩50.71 Billion | ₩- | ₩190.23 Billion | ▲ +6.4 pp |
| 2022 | 20.3% | ₩37.47 Billion | ₩37.47 Billion | ₩- | ₩184.95 Billion | ▲ +3.7 pp |
| 2021 | 16.5% | ₩30.52 Billion | ₩30.52 Billion | ₩- | ₩184.70 Billion | ▲ +0.1 pp |
| 2020 | 16.4% | ₩29.74 Billion | ₩29.74 Billion | ₩- | ₩181.13 Billion | ▲ +3.0 pp |
| 2019 | 13.4% | ₩24.12 Billion | ₩24.12 Billion | ₩- | ₩180.16 Billion | ▼ -7.7 pp |
| 2018 | 21.1% | ₩21.93 Billion | ₩17.27 Billion | ₩4.66 Billion | ₩103.98 Billion | ▲ +0.3 pp |
| 2017 | 20.8% | ₩20.34 Billion | ₩16.18 Billion | ₩4.15 Billion | ₩97.94 Billion | ▲ +2.8 pp |
| 2016 | 18.0% | ₩18.21 Billion | ₩16.91 Billion | ₩1.30 Billion | ₩101.11 Billion | ▼ -20.5 pp |
| 2015 | 38.5% | ₩18.02 Billion | ₩17.82 Billion | ₩202.00 Million | ₩46.81 Billion | ▼ -0.3 pp |
| 2014 | 38.8% | ₩19.04 Billion | ₩18.83 Billion | ₩202.00 Million | ₩49.00 Billion | ▲ +16.8 pp |
| 2013 | 22.1% | ₩10.81 Billion | ₩10.81 Billion | ₩- | ₩49.00 Billion | ▼ -7.4 pp |
| 2012 | 29.5% | ₩9.31 Billion | ₩9.31 Billion | ₩- | ₩31.59 Billion | ▼ -24.4 pp |
| 2011 | 53.8% | ₩9.71 Billion | ₩9.71 Billion | ₩- | ₩18.03 Billion | — |